State & Federal Compliance requirements are an ongoing challenge for EMS Agencies today, especially the evolving requirements related to narcotic storage and record keeping. BioConnect has designed the MedixSafe Retrofit Fit solution to help with the financial and operational challenge of aging infrastructure in the face of increasing stringent compliance requirements to continue as a licensed provider of controlled substances.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231206789133/en/
2023 EMS World Innovation Awards Winner Badge (Graphic: Business Wire)
The MedixSafe Retrofit Kit allows EMS Agencies, Pharmacies and other Healthcare facilities, many who have had safes installed for years, to keep their existing safes and easily transition to MedixSafe’s latest technology. The EMS Agency can easily replace the authentication device on the existing safe door and therefore benefit from higher levels of authentication (including Biometrics & Mobile Multi-Factor Authentication), compliance reporting and ongoing updates delivered through a cloud architecture.
“We are honored that the EMS World community recognizes the impact of our innovation allowing the retrofit of existing narcotic safes. The MedixSafe Retrofit Kit is not only just 25% the cost of buying a new safe from alternative providers, it is field upgradeable for future chain of custody requirements” commented Jeff Crews General Manager of BioConnect’s MedixSafe Business Unit. “EMS agencies now have a convenient cost-effective solution to not only upgrade their current safes to meet this year’s chain of custody requirements but to future proof the agency for changes to regulations in the future. We will continue to invest in incorporating the latest innovations into future versions of our solution to provide a cost-effective alternative for EMS Agencies to leverage their existing safe investments.”
The entire solution has been designed to allow the EMS Agency to self-install with convenient activation tools including a mobile set-up wizard, a web console to configure the safe within the EMS agencies specific IT requirements and a how-to-video for installation and activation. Solutions are also available for third party safes that use industry standard lock bodies to reduce the upgrade costs while upgrading to a centrally managed platform for higher levels of authentication, compliance reporting and ongoing updates delivered on a cloud architecture by a SOC2 certified organization.
About BioConnect:
Built by IT professionals for IT professionals, BioConnect provides an enterprise biometric authentication & security platform to establish stronger identity trust for the protection of the most valuable enterprise assets, their people, data and IP. For four consecutive years, BioConnect’s Trust Platform has received innovation awards from the Security Industry Association (SIA) along with being named a top quadrant leader in Access Control by Frost & Sullivan in 2022. Founded in Toronto, Canada in 2010, fast forward to today with over 2,500 customers predominantly in the USA and over 60 integration and strategic partnerships with leading security industry providers such as AMAG, Assa Abloy, Brivo, Convergint, Genetec, Johnson Controls, Lenel, and Software House.
In 2021, MedixSafe was purchased by BioConnect – a long time Medixsafe partner and supplier of biometric (fingerprint) solutions for secure access to MedixSafe devices.. Together BioConnect and MedixSafe are uniquely positioned to offer solutions to the toughest security problems that an organization faces, providing security at scale that establishes a strong level of trust by unifying a person’s identity across physical, IoT and digital applications.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231206789133/en/